237 results on '"Rawi, Reda"'
Search Results
2. Cholesterol reduction by immunization with a PCSK9 mimic
3. Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site
4. Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases
5. Cryo-EM structures of prefusion SIV envelope trimer
6. HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide
7. Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design
8. Vaccine elicitation and structural basis for antibody protection against alphaviruses
9. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses
10. A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination
11. Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody
12. Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
13. Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
14. Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces
15. Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
16. Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
17. Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain
18. Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5.
19. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
20. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization
21. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
22. Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates
23. Improvement of antibody functionality by structure-guided paratope engraftment
24. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
25. Correction to: Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project
26. Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project
27. Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite
28. Highly protective antimalarial antibodies via precision library generation and yeast display screening
29. Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site
30. Structural basis for llama nanobody recognition and neutralization of HIV-1
31. Highly protective antimalarial antibodies via precision library generation and yeast display screening
32. Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
33. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies
34. GLYCO: a tool to quantify glycan shielding of glycosylated proteins
35. Inference of global HIV-1 sequence patterns and preliminary feature analysis
36. Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography
37. Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses
38. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
39. Identification and structure of a multidonor class of head-directed influenza-neutralizing antibodies reveal the mechanism for its recurrent elicitation
40. Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains
41. Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation
42. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses
43. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition
44. VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage
45. CHOYCE: a web server for constrained homology modelling with cryoEM maps
46. MOESM3 of Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project
47. BCrystal: an interpretable sequence-based protein crystallization predictor
48. Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
49. Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting
50. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.